drugset / Trial / NCT05942963
Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
RandomizedFactorialSingle-blindTreatment
Summary
This clinical trial will yield results about the therapeutic effect of combining pioglitazone with SGLT2i in people suffering from NAFLD associated with T2DM. Study participants will be asked to fill out a few questions on proforma that will obtain demographic information as well as information relating to their health. In addition, some blood tests will be done following standard procedures.
Timeline
- Start
- 2023-10
- Primary completion
- 2024-04
- Completion
- 2024-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 10 mg | — |
| Subject | Pioglitazone | Small molecule | 15 mg | — |
| Background | Metformin | Small molecule | — | — |